@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen> a fhir:ValueSet ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "TreatmentRegimen"] ; # 
  fhir:text [
     fhir:status [ fhir:v "extensions" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet TreatmentRegimen</b></p><a name=\"TreatmentRegimen\"> </a><a name=\"hcTreatmentRegimen\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-TreatmentRegimen.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hydrea\">hydrea</a></td><td>Hydrea</td><td>Hydrea</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hdara_c\">hdara_c</a></td><td>HdAraC</td><td>Hd-Ara-c +- supplement</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087\">da31087</a></td><td>DA inkl. 3+10, 3+8, 3+7</td><td>DA inkl. 3+10, 3+8, 3+7</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087my\">da31087my</a></td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087mi\">da31087mi</a></td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-flagmito\">flagmito</a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-flagmitovene\">flagmitovene</a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-idarac\">idarac</a></td><td>IdAraC</td><td>IdAraC</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-apl_mt\">apl_mt</a></td><td>APL vedligehold</td><td>APL-vedligeholdsbehandling</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-azacitidinmono\">azacitidinmono</a></td><td>Azacitidin monoterapi</td><td>Azacitidin monoterapi</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-blinatumomab\">blinatumomab</a></td><td>Blinatumunab</td><td>Blinatumomab</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-vyxeos\">vyxeos</a></td><td>Vyxeos</td><td>Vyxeos +- supplement</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-nopho_2008\">nopho_2008</a></td><td>NOPHO 2008</td><td>NOPHO-2008</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-atoatra\">atoatra</a></td><td>ATO+ATRA</td><td>ATO+ATRA</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-aida\">aida</a></td><td>AIDA</td><td>AIDA</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-azacitidinvene\">azacitidinvene</a></td><td>Azacitidin-venetoclax</td><td>Azacitidin-venetoclax</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-toplusfem\">toplusfem</a></td><td>2+5 eller lign, eks. CT</td><td>2+5 eller lign, eks. CT</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-gilteritinib\">gilteritinib</a></td><td>Gilteritinib</td><td>Gilteritinib</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-midostaurin_ved\">midostaurin_ved</a></td><td>Midostaurin vedligehold</td><td>Midostaurin vedligehold</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-inotuzumab\">inotuzumab</a></td><td>Inotuzumab ozogamicin</td><td>Inotuzumab ozogamicin</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-all_ved\">all_ved</a></td><td>ALL vedligehold</td><td>ALL vedligehold</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hyper_cvad\">hyper_cvad</a></td><td>Hyper-CVAD</td><td>Hyper-CVAD</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-alltogether_mt\">alltogether_mt</a></td><td>ALLtogether</td><td>ALLtogether</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_ikke\">other_ikke</a></td><td>Anden ikke-intensiv</td><td>Anden ikke-intensiv</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_eks\">other_eks</a></td><td>Anden eksperimentel</td><td>Anden eksperimentel</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_semi\">other_semi</a></td><td>Anden semiintensiv (f.eks. Plan B)</td><td>Anden semiintensiv (f.eks. Plan B)</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_int\">other_int</a></td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td></tr></table></li></ul></div>"^^rdf:XMLLiteral
  ] ; # 
  fhir:url [ fhir:v "https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "2.12.2"] ; # 
  fhir:name [ fhir:v "TreatmentRegimen"] ; # 
  fhir:title [ fhir:v "Behandlingsplan"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v true] ; # 
  fhir:date [ fhir:v "2022-07-13T00:00:00+02:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"] ; # 
  fhir:contact ( [
     fhir:name [ fhir:v "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S" ] ;
     fhir:telecom ( [
       fhir:system [ fhir:v "url" ] ;
       fhir:value [ fhir:v "https://trifork.com" ]
     ] [
       fhir:system [ fhir:v "email" ] ;
       fhir:value [ fhir:v "rbk@trifork.com" ]
     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Behandlingsplan som beskriver specifikke codsering og planlægningen af behandling"] ; # 
  fhir:compose [
     fhir:include ( [
       fhir:system [ fhir:v "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen"^^xsd:anyURI ] ;
       fhir:concept ( [
         fhir:code [ fhir:v "hydrea" ] ;
         fhir:display [ fhir:v "Hydrea" ]
       ] [
         fhir:code [ fhir:v "hdara_c" ] ;
         fhir:display [ fhir:v "HdAraC" ]
       ] [
         fhir:code [ fhir:v "da31087" ] ;
         fhir:display [ fhir:v "DA inkl. 3+10, 3+8, 3+7" ]
       ] [
         fhir:code [ fhir:v "da31087my" ] ;
         fhir:display [ fhir:v "DA inkl. 3+10, 3+8, 3+7 + mylotarg" ]
       ] [
         fhir:code [ fhir:v "da31087mi" ] ;
         fhir:display [ fhir:v "DA inkl. 3+10, 3+8, 3+7 + midostaurin" ]
       ] [
         fhir:code [ fhir:v "flagmito" ] ;
         fhir:display [ fhir:v "FLAG-Ida eller lign inkl FLAG, Mito-FLAG" ]
       ] [
         fhir:code [ fhir:v "flagmitovene" ] ;
         fhir:display [ fhir:v "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax" ]
       ] [
         fhir:code [ fhir:v "idarac" ] ;
         fhir:display [ fhir:v "IdAraC" ]
       ] [
         fhir:code [ fhir:v "apl_mt" ] ;
         fhir:display [ fhir:v "APL vedligehold" ]
       ] [
         fhir:code [ fhir:v "azacitidinmono" ] ;
         fhir:display [ fhir:v "Azacitidin monoterapi" ]
       ] [
         fhir:code [ fhir:v "blinatumomab" ] ;
         fhir:display [ fhir:v "Blinatumunab" ]
       ] [
         fhir:code [ fhir:v "vyxeos" ] ;
         fhir:display [ fhir:v "Vyxeos" ]
       ] [
         fhir:code [ fhir:v "nopho_2008" ] ;
         fhir:display [ fhir:v "NOPHO 2008" ]
       ] [
         fhir:code [ fhir:v "atoatra" ] ;
         fhir:display [ fhir:v "ATO+ATRA" ]
       ] [
         fhir:code [ fhir:v "aida" ] ;
         fhir:display [ fhir:v "AIDA" ]
       ] [
         fhir:code [ fhir:v "azacitidinvene" ] ;
         fhir:display [ fhir:v "Azacitidin-venetoclax" ]
       ] [
         fhir:code [ fhir:v "toplusfem" ] ;
         fhir:display [ fhir:v "2+5 eller lign, eks. CT" ]
       ] [
         fhir:code [ fhir:v "gilteritinib" ] ;
         fhir:display [ fhir:v "Gilteritinib" ]
       ] [
         fhir:code [ fhir:v "midostaurin_ved" ] ;
         fhir:display [ fhir:v "Midostaurin vedligehold" ]
       ] [
         fhir:code [ fhir:v "inotuzumab" ] ;
         fhir:display [ fhir:v "Inotuzumab ozogamicin" ]
       ] [
         fhir:code [ fhir:v "all_ved" ] ;
         fhir:display [ fhir:v "ALL vedligehold" ]
       ] [
         fhir:code [ fhir:v "hyper_cvad" ] ;
         fhir:display [ fhir:v "Hyper-CVAD" ]
       ] [
         fhir:code [ fhir:v "alltogether_mt" ] ;
         fhir:display [ fhir:v "ALLtogether" ]
       ] [
         fhir:code [ fhir:v "other_ikke" ] ;
         fhir:display [ fhir:v "Anden ikke-intensiv" ]
       ] [
         fhir:code [ fhir:v "other_eks" ] ;
         fhir:display [ fhir:v "Anden eksperimentel" ]
       ] [
         fhir:code [ fhir:v "other_semi" ] ;
         fhir:display [ fhir:v "Anden semiintensiv (f.eks. Plan B)" ]
       ] [
         fhir:code [ fhir:v "other_int" ] ;
         fhir:display [ fhir:v "Anden intensiv (f.eks. BISHOP, Plan A)" ]
       ] )
     ] )
  ] . # 

# -------------------------------------------------------------------------------------

